TY - JOUR
T1 - Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS)
AU - Alméciga-Díaz, Carlos Javier
AU - Tolosa-Díaz, Andrés Dario
AU - Pimentel, Luisa Natalia
AU - Bonilla, Yahir Andres
AU - Rodríguez-López, Alexander
AU - Espejo-Mojica, Angela J.
AU - Patiño, Juan D.
AU - Sánchez, Oscar F.
AU - Gonzalez-Santos, Janneth
PY - 2017/11/15
Y1 - 2017/11/15
N2 - Maturation of type I sulfatases requires the conversion of the cysteine (Cys) or serine (Ser) present in the active site to formylglycine (FGly). This activation represents a limiting step during the production of recombinant sulfatases in bacteria and eukaryotic hosts. AslB, YdeM and YidF have been proposed to participate in the activation of sulfatases in Escherichia coli. In this study, we combined in-silico and experimental approaches to study the interaction between Escherichia coli BL21(DE3) AslB and human sulfatases, more specifically iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS). In-silico results show that AslB has a higher affinity for the residual motif of GALNS (− 9.4 kcal mol− 1), Cys- and Ser-type, than for the one of IDS (− 8.0 kcal mol− 1). However, the distance between the AslB active residue and the target motif favors the interaction with IDS (4.4 Å) more than with GALNS (5.5 Å). Experimental observations supported in-silico results where the co-expression of AslB with GALNS Cys- and Ser-type presented an activity increment of 2.0- and 1.5-fold compared to the control cultures, lacking overexpressed AslB. Similarly, IDS activity was increased in 4.6-fold when co-expressed with AslB. The higher sulfatase activity of AslB-IDS suggests that the distance between the AslB active residue and the motif target is a key parameter for the in-silico search of potential sulfatase activators. In conclusion, our results suggest that AslB is involve in the maturation of heterologous human sulfatases in E. coli BL21(DE3), and that it can have important implications in the production of recombinant sulfatases for therapeutic purposes and research.
AB - Maturation of type I sulfatases requires the conversion of the cysteine (Cys) or serine (Ser) present in the active site to formylglycine (FGly). This activation represents a limiting step during the production of recombinant sulfatases in bacteria and eukaryotic hosts. AslB, YdeM and YidF have been proposed to participate in the activation of sulfatases in Escherichia coli. In this study, we combined in-silico and experimental approaches to study the interaction between Escherichia coli BL21(DE3) AslB and human sulfatases, more specifically iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS). In-silico results show that AslB has a higher affinity for the residual motif of GALNS (− 9.4 kcal mol− 1), Cys- and Ser-type, than for the one of IDS (− 8.0 kcal mol− 1). However, the distance between the AslB active residue and the target motif favors the interaction with IDS (4.4 Å) more than with GALNS (5.5 Å). Experimental observations supported in-silico results where the co-expression of AslB with GALNS Cys- and Ser-type presented an activity increment of 2.0- and 1.5-fold compared to the control cultures, lacking overexpressed AslB. Similarly, IDS activity was increased in 4.6-fold when co-expressed with AslB. The higher sulfatase activity of AslB-IDS suggests that the distance between the AslB active residue and the motif target is a key parameter for the in-silico search of potential sulfatase activators. In conclusion, our results suggest that AslB is involve in the maturation of heterologous human sulfatases in E. coli BL21(DE3), and that it can have important implications in the production of recombinant sulfatases for therapeutic purposes and research.
UR - http://www.scopus.com/inward/record.url?scp=85030621013&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030621013&partnerID=8YFLogxK
U2 - 10.1016/j.gene.2017.08.043
DO - 10.1016/j.gene.2017.08.043
M3 - Research Article
C2 - 28882567
AN - SCOPUS:85030621013
SN - 0378-1119
VL - 634
SP - 53
EP - 61
JO - Gene
JF - Gene
ER -